MIVURA



Trademark Coverage

No Class Specified

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan

Owner
Timeline
  • Jan 22
    2014
    Attorney Revoked And/Or Appointed
  • Jan 22
    2014
    TEAS Revoke/Appoint Attorney Received
  • Mar 23
    2011
    Assignment Of Ownership Not Updated Automatically
  • Mar 21
    2011
    Abandonment Notice Mailed No Use Statement Filed
  • Mar 21
    2011
    Abandonment No Use Statement Filed
  • Oct 13
    2010
    Assignment Of Ownership Not Updated Automatically
  • Aug 25
    2010
    Notice Of Approval Of Extension Request E Mailed
  • Aug 24
    2010
    Extension 5 Granted
  • Aug 16
    2010
    Extension 5 Filed
  • Aug 16
    2010
    TEAS Extension Received
  • Feb 11
    2010
    Extension 4 Granted
  • Feb 04
    2010
    Extension 4 Filed
  • Feb 04
    2010
    TEAS Extension Received
  • Aug 13
    2009
    Extension 3 Granted
  • Aug 12
    2009
    Extension 3 Filed
  • Aug 12
    2009
    TEAS Extension Received
  • Jun 17
    2009
    Assignment Of Ownership Not Updated Automatically
  • Mar 03
    2009
    Extension 2 Granted
  • Feb 13
    2009
    Extension 2 Filed
  • Mar 03
    2009
    Case Assigned To Intent To Use Paralegal
  • Feb 13
    2009
    TEAS Extension Received
  • Jan 22
    2009
    Applicant/Correspondence Changes (Non Responsive) Entered
  • Jan 22
    2009
    TEAS Change Of Owner Address Received
  • Aug 12
    2008
    Extension 1 Granted
  • Aug 12
    2008
    Extension 1 Filed
  • Aug 12
    2008
    TEAS Extension Received
  • Feb 19
    2008
    NOA Mailed SOU Required From Applicant
  • Dec 07
    2007
    Changes/Corrections After PUB Approval Entered
  • Nov 30
    2007
    Fax Received
  • Nov 27
    2007
    Published For Opposition
  • Nov 07
    2007
    Notice Of Publication
  • Oct 19
    2007
    Law Office Publication Review Completed
  • Oct 19
    2007
    Assigned To LIE
  • Sep 29
    2007
    TEAS Change Of Correspondence Received
  • Sep 18
    2007
    Approved For PUB Principal Register
  • Sep 13
    2007
    TEAS/Email Correspondence Entered
  • Sep 12
    2007
    Correspondence Received In Law Office
  • Sep 12
    2007
    TEAS Change Of Correspondence Received
  • Sep 12
    2007
    TEAS Request For Reconsideration Received
  • Mar 14
    2007
    Final Refusal E Mailed
  • Mar 14
    2007
    Final Refusal Written
  • Mar 13
    2007
    TEAS/Email Correspondence Entered
  • Mar 13
    2007
    Correspondence Received In Law Office
  • Mar 13
    2007
    TEAS Response To Office Action Received
  • Sep 19
    2006
    TEAS Change Of Correspondence Received
  • Sep 13
    2006
    Non Final Action E Mailed
  • Sep 13
    2006
    Non Final Action Written
  • Sep 13
    2006
    Assigned To Examiner
  • Apr 06
    2006
    New Application Entered In TRAM